{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Treatment+Response&page=20", "query": { "condition": "Treatment Response", "page": 20 }, "page_size": 10 }, "pagination": { "page": 20, "page_size": 10, "total_count": 2298, "total_pages": 230, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Treatment+Response&page=21&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Treatment+Response&page=19&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-08T04:04:33.887Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01356160", "title": "GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hepatitis C, Chronic" ], "interventions": [ { "name": "GS-5885", "type": "DRUG" }, { "name": "GS-9451", "type": "DRUG" }, { "name": "peginterferon alfa-2a", "type": "BIOLOGICAL" }, { "name": "ribavirin tablet", "type": "DRUG" }, { "name": "GS-9451 Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 351, "start_date": "2011-07", "completion_date": "2013-06", "has_results": false, "last_update_posted_date": "2014-02-03", "last_synced_at": "2026-11-08T04:04:33.887Z", "location_count": 21, "location_summary": "Tucson, Arizona • Beverly Hills, California • Coronado, California + 17 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Coronado", "state": "California" }, { "city": "Costa Mesa", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01356160" }, { "nct_id": "NCT01724463", "title": "Electronic Application of a Severe Sepsis Screening Tool and Management Bundle", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Systemic Inflammatory Response Syndrome (SIRS)", "Sepsis", "Severe Sepsis", "Septic Shock" ], "interventions": [ { "name": "Severe Sepsis Management Bundle", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Tennessee", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Month", "maximum_age": "18 Years", "sex": "ALL", "summary": "1 Month to 18 Years" }, "enrollment_count": 30000, "start_date": "2013-03", "completion_date": "2018-10", "has_results": false, "last_update_posted_date": "2015-03-31", "last_synced_at": "2026-11-08T04:04:33.887Z", "location_count": 1, "location_summary": "Memphis, Tennessee", "locations": [ { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT01724463" }, { "nct_id": "NCT06580314", "title": "Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Fallopian Tube Endometrioid Adenocarcinoma", "Fallopian Tube High Grade Serous Adenocarcinoma", "Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor", "FIGO Stage III Ovarian Cancer 2014", "FIGO Stage IV Ovarian Cancer 2014", "Ovarian Carcinoma", "Ovarian Carcinosarcoma", "Ovarian High Grade Endometrioid Adenocarcinoma", "Ovarian High Grade Serous Adenocarcinoma", "Primary Peritoneal Carcinosarcoma", "Primary Peritoneal Endometrioid Adenocarcinoma", "Primary Peritoneal High Grade Serous Adenocarcinoma" ], "interventions": [ { "name": "Bevacizumab", "type": "BIOLOGICAL" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Olaparib", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "PROCEDURE", "DRUG" ], "sponsor": "NRG Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 880, "start_date": "2025-03-12", "completion_date": "2034-12-31", "has_results": false, "last_update_posted_date": "2026-08-07", "last_synced_at": "2026-11-08T04:04:33.887Z", "location_count": 676, "location_summary": "Birmingham, Alabama • Anchorage, Alaska • Fairbanks, Alaska + 458 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" } ], "official_url": "https://clinicaltrials.gov/study/NCT06580314" }, { "nct_id": "NCT07146438", "title": "Transcranial Magnetic Stimulation and Psychotherapy for Treating Obsessive-Compulsive Disorder", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obsessive - Compulsive Disorder" ], "interventions": [ { "name": "Repetitive Transcranial Magnetic Stimulation (rTMS)", "type": "DEVICE" }, { "name": "Supportive Therapy (ST)", "type": "BEHAVIORAL" }, { "name": "Exposure and Response Prevention (ERP) Therapy", "type": "BEHAVIORAL" } ], "intervention_types": [ "DEVICE", "BEHAVIORAL" ], "sponsor": "Adam Frank", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 48, "start_date": "2025-11-10", "completion_date": "2028-08", "has_results": false, "last_update_posted_date": "2025-10-27", "last_synced_at": "2026-11-08T04:04:33.887Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07146438" }, { "nct_id": "NCT06765317", "title": "A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diffuse Large B Cell Lymphoma (DLBCL)", "High Grade B Cell Lymphoma" ], "interventions": [ { "name": "Glofitamab", "type": "DRUG" }, { "name": "Polatuzumab", "type": "DRUG" }, { "name": "Rituximab", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Obinutuzumab:", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "65 Years to 80 Years" }, "enrollment_count": 42, "start_date": "2025-01-16", "completion_date": "2028-01", "has_results": false, "last_update_posted_date": "2026-10-30", "last_synced_at": "2026-11-08T04:04:33.887Z", "location_count": 8, "location_summary": "Basking Ridge, New Jersey • Hackensack, New Jersey • Middletown, New Jersey + 5 more", "locations": [ { "city": "Basking Ridge", "state": "New Jersey" }, { "city": "Hackensack", "state": "New Jersey" }, { "city": "Middletown", "state": "New Jersey" }, { "city": "Montvale", "state": "New Jersey" }, { "city": "Commack", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06765317" }, { "nct_id": "NCT03509350", "title": "Vitamin C, Thiamine, and Steroids in Sepsis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Sepsis" ], "interventions": [ { "name": "Vitamin C", "type": "DRUG" }, { "name": "Thiamine", "type": "DRUG" }, { "name": "Hydrocortisone", "type": "DRUG" }, { "name": "Vitamin C Placebo", "type": "DRUG" }, { "name": "Thiamine Placebo", "type": "DRUG" }, { "name": "Hydrocortisone Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 501, "start_date": "2018-08-22", "completion_date": "2020-01-29", "has_results": true, "last_update_posted_date": "2021-04-13", "last_synced_at": "2026-11-08T04:04:33.887Z", "location_count": 43, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Los Angeles, California + 30 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03509350" }, { "nct_id": "NCT06126263", "title": "Adjunctive Clindamycin Versus Linezolid for β-lactam Treated Patients With Invasive Group A Streptococcal Infections", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Streptococcal Sepsis", "Invasive Group A Beta-Haemolytic Streptococcal Disease", "Necrotizing Soft Tissue Infection", "Infection, Bloodstream", "Infection, Bacterial", "Streptococcal Toxic Shock Syndrome" ], "interventions": [ { "name": "Linezolid", "type": "DRUG" }, { "name": "Clindamycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institutes of Health Clinical Center (CC)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 1000, "start_date": "2023-01-01", "completion_date": "2024-06-30", "has_results": false, "last_update_posted_date": "2023-11-13", "last_synced_at": "2026-11-08T04:04:33.887Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT06126263" }, { "nct_id": "NCT01832493", "title": "Sensor Optimization of Cardiac Resynchronization Therapy Response", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Heart Failure" ], "interventions": [ { "name": "Cardiac Resynchronization Therapy", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Medtronic Cardiac Rhythm and Heart Failure", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2013-07", "completion_date": "2016-06", "has_results": true, "last_update_posted_date": "2016-08-29", "last_synced_at": "2026-11-08T04:04:33.887Z", "location_count": 3, "location_summary": "Des Moines, Iowa • Columbus, Ohio • Fairfield, Ohio", "locations": [ { "city": "Des Moines", "state": "Iowa" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Fairfield", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01832493" }, { "nct_id": "NCT05224414", "title": "Interpretation Bias as a Mechanism of Treatment Response in OCD", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obsessive-Compulsive Disorder" ], "interventions": [ { "name": "Cognitive bias modification for interpretation bias", "type": "BEHAVIORAL" }, { "name": "Psychoeducation", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Mclean Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 106, "start_date": "2022-03-30", "completion_date": "2026-08-31", "has_results": false, "last_update_posted_date": "2026-05-18", "last_synced_at": "2026-11-08T04:04:33.887Z", "location_count": 1, "location_summary": "Belmont, Massachusetts", "locations": [ { "city": "Belmont", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05224414" }, { "nct_id": "NCT00392938", "title": "Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Metastatic Cancer", "Prostate Cancer" ], "interventions": [ { "name": "antiandrogen therapy", "type": "DRUG" }, { "name": "docetaxel", "type": "DRUG" }, { "name": "C-11 acetate PET scan", "type": "DIAGNOSTIC_TEST" }, { "name": "F-18 FDG PET scan", "type": "DIAGNOSTIC_TEST" }, { "name": "Tc-99m bone scan", "type": "DIAGNOSTIC_TEST" }, { "name": "CT scan of the chest, abdomen and pelvis", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DRUG", "DIAGNOSTIC_TEST" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "MALE", "summary": "18 Years to 120 Years · Male only" }, "enrollment_count": 11, "start_date": "2005-12", "completion_date": null, "has_results": false, "last_update_posted_date": "2017-03-13", "last_synced_at": "2026-11-08T04:04:33.887Z", "location_count": 2, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00392938" } ] }